Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2005 1
2006 1
2007 1
2008 2
2009 1
2010 2
2011 1
2012 1
2013 4
2014 4
2015 4
2016 5
2017 5
2018 7
2019 3
2020 3
2021 1
2022 1
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives.
Barchiesi G, Mazzotta M, Krasniqi E, Pizzuti L, Marinelli D, Capomolla E, Sergi D, Amodio A, Natoli C, Gamucci T, Vizza E, Marchetti P, Botti C, Sanguineti G, Ciliberto G, Barba M, Vici P. Barchiesi G, et al. Int J Mol Sci. 2020 May 16;21(10):3528. doi: 10.3390/ijms21103528. Int J Mol Sci. 2020. PMID: 32429381 Free PMC article. Review.
We herein present historical data regarding Tamoxifen and/or Aromatase Inhibitors and a debate on recent evidence regarding agents such as CDK4/6 and PI3K/mTOR inhibitors in the neoadjuvant setting. ...
We herein present historical data regarding Tamoxifen and/or Aromatase Inhibitors and a debate on recent evidence regarding agents su …
Prognostic and predictive biomarkers in breast cancer: Past, present and future.
Nicolini A, Ferrari P, Duffy MJ. Nicolini A, et al. Semin Cancer Biol. 2018 Oct;52(Pt 1):56-73. doi: 10.1016/j.semcancer.2017.08.010. Epub 2017 Sep 4. Semin Cancer Biol. 2018. PMID: 28882552 Review.
A promising ctDNA biomarker is the mutational status of ER (ESR1) for predicting the emergence of resistance to aromatase inhibitors. Challenges for future research include the identification of biomarkers for predicting response to radiotherapy and specific forms of chemo …
A promising ctDNA biomarker is the mutational status of ER (ESR1) for predicting the emergence of resistance to aromatase inhibitors. …
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial.
Loibl S, Marmé F, Martin M, Untch M, Bonnefoi H, Kim SB, Bear H, McCarthy N, Melé Olivé M, Gelmon K, García-Sáenz J, Kelly CM, Reimer T, Toi M, Rugo HS, Denkert C, Gnant M, Makris A, Koehler M, Huang-Bartelett C, Lechuga Frean MJ, Colleoni M, Werutsky G, Seiler S, Burchardi N, Nekljudova V, von Minckwitz G. Loibl S, et al. J Clin Oncol. 2021 May 10;39(14):1518-1530. doi: 10.1200/JCO.20.03639. Epub 2021 Apr 1. J Clin Oncol. 2021. PMID: 33793299 Clinical Trial.
The median age was 49.0 years (range, 19-79), and the majority were ypN+ with Ki-67 15%; 59.4% of patients had a clinical pathological staging-estrogen receptor grading score 3. 50.1% received aromatase inhibitor, and 33% of premenopausal women received a luteinizing hormo …
The median age was 49.0 years (range, 19-79), and the majority were ypN+ with Ki-67 15%; 59.4% of patients had a clinical pathological stagi …
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients.
Sini V, Botticelli A, Lunardi G, Gori S, Marchetti P. Sini V, et al. Pharmacogenomics. 2017 Jun;18(8):821-830. doi: 10.2217/pgs-2017-0006. Epub 2017 Jun 8. Pharmacogenomics. 2017. PMID: 28592202 Review.
This paper reviews genetic variations mainly related to the onset of adverse events during aromatase inhibitors in early breast cancer. Genetic variability could occur at different steps. The analysis included studies that involved breast cancer patients, treated with an …
This paper reviews genetic variations mainly related to the onset of adverse events during aromatase inhibitors in early breast cance …
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.
Eisen A, Trudeau M, Shelley W, Messersmith H, Pritchard KI. Eisen A, et al. Cancer Treat Rev. 2008 Apr;34(2):157-74. doi: 10.1016/j.ctrv.2007.11.001. Epub 2007 Dec 31. Cancer Treat Rev. 2008. PMID: 18164821 Review.
BACKGROUND: A systematic review was undertaken to review the evidence for the use of third-generation aromatase inhibitors (anastrozole, letrozole and exemestane) as adjuvant therapy for post-menopausal women with early-stage, hormone receptor-positive breast cancer and to …
BACKGROUND: A systematic review was undertaken to review the evidence for the use of third-generation aromatase inhibitors (anastrozo …
Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: new questions--old answers?
Ebert AD, Bartley J, David M. Ebert AD, et al. Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):144-50. doi: 10.1016/j.ejogrb.2005.04.017. Epub 2005 Sep 12. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 16157442 Review.
Aromatase (p450arom) is responsible for converting C19 androgens into estrogen in several types of human tissue. ...Thus, specific aromatase inhibitors (e.g. Letrozol/Femara, Anastrozol/Arimidex or Exemestan/Aromasin) or selective COX-2 inhibitors (e.g. ...
Aromatase (p450arom) is responsible for converting C19 androgens into estrogen in several types of human tissue. ...Thus, specific …
[Aromatase inhibitors--theoretical concept and present experiences in the treatment of endometriosis].
Ebert AD, Bartley J, David M, Schweppe KW. Ebert AD, et al. Zentralbl Gynakol. 2003 Jul-Aug;125(7-8):247-51. doi: 10.1055/s-2003-42517. Zentralbl Gynakol. 2003. PMID: 14505258 Review. German.
Aromatase (p450arom) is responsible for conversion of C19 androgens to estrogen in several human tissues. ...In several human cell lines, prostaglandin and estrogen concentrations are associated with proliferation, migration, angiogenesis, apoptosis resistance, and even in …
Aromatase (p450arom) is responsible for conversion of C19 androgens to estrogen in several human tissues. ...In several human cell li …
Pharmacologic treatment of the ovarian endometrioma.
Benagiano G, Guo SW, Bianchi P, Puttemans P, Gordts S, Petraglia F, Brosens I. Benagiano G, et al. Expert Opin Pharmacother. 2016 Oct;17(15):2019-31. doi: 10.1080/14656566.2016.1229305. Epub 2016 Sep 20. Expert Opin Pharmacother. 2016. PMID: 27615386 Review.
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
Antonini S, Pedersini R, Birtolo MF, Baruch NL, Carrone F, Jaafar S, Ciafardini A, Cosentini D, Laganà M, Torrisi R, Farina D, Leonardi L, Balzarini L, Vena W, Bossi AC, Zambelli A, Lania AG, Berruti A, Mazziotti G. Antonini S, et al. J Endocrinol Invest. 2024 Feb;47(2):433-442. doi: 10.1007/s40618-023-02174-5. Epub 2023 Aug 17. J Endocrinol Invest. 2024. PMID: 37592052
The value of TBS in predicting fractures and the effects of bone-active drugs on TBS in aromatase inhibitors (AIs)-induced osteoporosis are still largely unknown. ...
The value of TBS in predicting fractures and the effects of bone-active drugs on TBS in aromatase inhibitors (AIs)-induced osteoporos …
Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options.
Grizzi G, Ghidini M, Botticelli A, Tomasello G, Ghidini A, Grossi F, Fusco N, Cabiddu M, Savio T, Petrelli F. Grizzi G, et al. Cancer Manag Res. 2020 Jan 30;12:675-686. doi: 10.2147/CMAR.S202965. eCollection 2020. Cancer Manag Res. 2020. PMID: 32099464 Free PMC article. Review.
However, the low pathologic complete response rate (pCR) obtained with tamoxifen or aromatase inhibitors (AIs) alone does not make NEO-HT as a suitable option for the neoadjuvant treatment of HR+ HER2-. ...
However, the low pathologic complete response rate (pCR) obtained with tamoxifen or aromatase inhibitors (AIs) alone does not make NE …
46 results